← Evidence map

ArticleCureus2022

Comparing the Efficacy and Safety of Apixaban Versus Warfarin in Morbidly Obese Patients.

Sultan N Alotaibi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36407232